Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 1:306:39-46.
doi: 10.1016/j.jad.2022.02.073. Epub 2022 Mar 3.

C-reactive protein and affective inhibition in bipolar disorder

Affiliations

C-reactive protein and affective inhibition in bipolar disorder

Amy T Peters et al. J Affect Disord. .

Abstract

Background: Individuals with bipolar disorder (BD) experience cognitive and affective processing deficits that often persist beyond the remission of acute mood symptoms. One possible biological mechanism for these deficits involves the potential effects of chronic low-grade peripheral inflammation on brain function. Peripheral inflammation has been associated with reduced executive functioning and memory performance, as well as altered reward processing in BD, but whether it is also implicated in cognitive-affective processing remains unknown.

Method: Peripheral inflammation was measured by serum C-reactive protein (CRP) in 119 adults with BD I or II, age 18-65. All participants completed the Affective Go/No-Go Task, a measure of cognitive-emotional processing. Correlations of CRP with discrimination of and response times to Negative, Positive, and Neutral words were performed before and after adjustment for severity of residual depressive symptoms and other demographic and clinical characteristics associated with inflammation.

Results: Increased CRP was significantly associated with reduced negative target discriminability, which was also significantly reduced compared to positive and neutral target conditions. Additionally, greater CRP was associated with faster response times for both negative hits and commissions, as well as positive commissions.

Conclusions: This study adds to existing research demonstrating associations between inflammation and cognition or reward sensitivity and motivation separately in BD, by raising the possibility that inflammation is also implicated in the integration of cognitive-affective processing. Assessment of these associations over time is warranted to determine involvement of inflammation and cognitive-emotional processing in course of illness and identify critical periods for possible modulation of inflammation.

Keywords: Affective inhibition; Bipolar disorder; C-reactive protein; Cognition; Inflammation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
This is a schematic of the Affective Go/No-Go Task Diagram. In the first representation, the target valence is negative. When a word with negative valence is displayed, the participant presses the response button (“Go” condition”). When a word with a positive valence is presented, the participant must withhold a response (“No Go”). In the second representation, the target valence is positive. When a word with positive valence is displayed, the participant presses the response button (“Go” condition”). When a word with a negative valence is presented, the participant must withhold a response (“No Go”).
Figure 2.
Figure 2.
Average detection accuracy and response times during Affective Go/No-go performance
Figure 3.
Figure 3.
Univariate associations of CRP and affective inhibition performance measures of: A) d prime; B) Hits RT (Response Times); C) Commissions RT. Negative Commissions RT, n = 118 due to 1 subject with 0% commissions rate. Positive Hits RT, n = 117 due to 2 subjects with 0% hit rate. Neutral Commissions RT, n = 117 due to 2 subjects with 0% commissions rate.

Similar articles

Cited by

References

    1. Mann-Wrobel MC, Carreno JT, Dickinson D. Meta-analysis of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables. Bipolar Disord. 2011;13(4):334–342. - PubMed
    1. Van Rheenen TE, Lewandowski KE, Tan EJ, et al. Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum. Psychol Med. 2017;47(10):1848–1864. - PubMed
    1. Burdick KE, Russo M, Frangou S, et al. Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications. Psychol Med. 2014;44(14):3083–3096. - PMC - PubMed
    1. Langenecker SA, Saunders EF, Kade AM, Ransom MT, McInnis MG. Intermediate: cognitive phenotypes in bipolar disorder. J Affect Disord. 2010;122(3):285–293. - PMC - PubMed
    1. Bora E, Yucel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord. 2009;113(1–2):1–20. - PubMed